Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,847
datasets available to search
ShareScore release 0.9.0
Dataset results
1,847 results for “Psoriasis”
An Investigator Initiated Open Label Study Evaluating the Efficacy and Tolerability of Oral Deucravacitinib for the Treatment of Nail Psoriasis
ClinicalTrials.gov study NCT05124080. IPD Sharing: NO. Countries: 1. Publications: 0.
Monitoring and Modifying Atherosclerosis in Psoriasis Patients Study
ClinicalTrials.gov study NCT01522742. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Topical Double-blind, Randomized, Placebo-controlled Study in Psoriasis Patients
ClinicalTrials.gov study NCT01936337. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Study to Assess the Change in Disease State When Subcutaneous Risankizumab Injection is Given to Adult Participants With Psoriasis in Taiwan
ClinicalTrials.gov study NCT04818385. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Icotinib Hydrochloride Cream in Healthy Adults and Psoriasis Patients
ClinicalTrials.gov study NCT02574091. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Tetrathiomolybdate in the Treatment of Psoriasis Vulgaris
ClinicalTrials.gov study NCT00113542. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Assess the Long-term Effectiveness and Safety of Amevive (Alefacept) in Subjects With Moderate to Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT00795353. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Effect of Algae Dunaliella Bardawil on Psoriasis (2)
ClinicalTrials.gov study NCT01121081. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Efficacy and Safety of SHR-1314 in the Treatment of Pediatric Patients of Age 6 to <18 Years With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT06833307. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Real-World Safety and Effectiveness of Sotyktu (Deucravacitinib) in Patients With Moderate-to-Severe Plaque Psoriasis in Korea
ClinicalTrials.gov study NCT06258668. IPD Sharing: NO. Countries: 1. Publications: 0.
Augmenting Standard-of-care Treatment of Plaque Psoriasis by Neuromodulation
ClinicalTrials.gov study NCT05243303. IPD Sharing: NO. Countries: 1. Publications: 0.
Alefacept in Subjects With Chronic Plaque Psoriasis Who Failed to Respond to Anti-TNF Therapy
ClinicalTrials.gov study NCT00953329. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Safety Study of Multiple Subcutaneous (s.c.) Injections of SHR-1314 in Adults With Moderate-to-severe Plaque Psoriasis
ClinicalTrials.gov study NCT03710681. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bicillin L-A vs Placebo for the Treatment of Chronic, Plaque-Type Psoriasis Unresponsive to Topical Medications
ClinicalTrials.gov study NCT00427609. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Therapeutic Drug Monitoring of Brodalumab in Psoriasis Patients (BIOLOPTIM-BRO)
ClinicalTrials.gov study NCT04080635. IPD Sharing: NO. Countries: 1. Publications: 0.
Low-Salt Diet Effect on Th17-Mediated Inflammation and Vascular Reactivity in Psoriasis
ClinicalTrials.gov study NCT05892640. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase II Efficacy and Safety Study of HSK44459 in Subjects With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT07150988. IPD Sharing: NO. Countries: 1. Publications: 0.
Secukinumab Therapy for the Treatment of Moderate to Severe Plaque Psoriasis With Response Monitoring Using Optical Coherence Tomography (OCT).
ClinicalTrials.gov study NCT03307447. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients with Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT06109818. IPD Sharing: NO. Countries: 1. Publications: 0.
Tolerability, Safety and Pharmacokinetic Study of Humanized Anti-CD6 Monoclonal Antibody Injection in Chinese Psoriasis
ClinicalTrials.gov study NCT02649270. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.